AI in drug discovery: the future is near
The Register - 22-Jan-2025Machine learning promises faster, cheaper, and more effective treatments
Join the club for FREE to access the whole archive and other member benefits.
Company developing AI systems for solving problems
Google DeepMind brings together two of the world’s leading AI labs — Google Brain and DeepMind — into a single, focused team led by our CEO Demis Hassabis. Over the last decade, the two teams were responsible for some of the biggest research breakthroughs in AI, many of which underpin the flourishing AI industry we see today.
DeepMind started in 2010, with an interdisciplinary approach to building general AI systems. The research lab brought together new ideas and advances in machine learning, neuroscience, engineering, mathematics, simulation and computing infrastructure, along with new ways of organizing scientific endeavors.
The lab achieved early success by pioneering the field of deep reinforcement learning - a combination of deep learning and reinforcement learning - and using games to test its systems. One of its early breakthroughs was a program called DQN, which learned to play 49 different Atari games from scratch just by observing the raw pixels on the screen and being told to maximize the score.
Visit website: https://deepmind.google/
Details last updated 29-Nov-2019
Machine learning promises faster, cheaper, and more effective treatments
AI transforms how we understand and target proteins
Balancing productivity gains with the risk of low-quality research
AlphaProteo redefines protein design with groundbreaking AI accuracy
The breakthrough could revolutionize drug discovery and disease treatment
In Deep Medicine, leading physician Eric Topol reveals how artificial intelligence can help
Mustafa Suleyman CBE is a British entrepreneur, activist and, most notably, the co-founder and Head of Applied AI at DeepMind